Mustang Bio Inc. (MBIO)
NASDAQ: MBIO
· Real-Time Price · USD
1.76
-0.02 (-1.12%)
At close: Aug 15, 2025, 3:49 PM
-1.12% (1D)
| Bid | 1.74 |
| Market Cap | 12.74M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.71M |
| EPS (ttm) | 1.99 |
| PE Ratio (ttm) | 0.88 |
| Forward PE | -0.02 |
| Analyst | Buy |
| Ask | 1.79 |
| Volume | 88,754 |
| Avg. Volume (20D) | 5,844,319 |
| Open | 1.76 |
| Previous Close | 1.78 |
| Day's Range | 1.71 - 1.80 |
| 52-Week Range | 0.89 - 21.95 |
| Beta | 2.23 |
About MBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+180.67%
Mustang Bio shares are trading higher after the co...
Unlock content with
Pro Subscription
1 month ago
+114.64%
Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.
